🇺🇸 FDA
Patent

US 7879798

Composition for indolent wound healing and methods of use therefor

granted A61KA61K31/07A61K31/355

Quick answer

US patent 7879798 (Composition for indolent wound healing and methods of use therefor) held by Regenicel, Inc. expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regenicel, Inc.
Grant date
Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/07, A61K31/355, A61K31/59, A61K38/12